Covid-19 and diabetes: A collision and collusion of two diseases

Eva L. Feldman, Masha G. Savelieff, Salim S. Hayek, Subramaniam Pennathur, Matthias Kretzler, Rodica Pop-Busui

Research output: Contribution to journalArticlepeer-review


The coronavirus disease 2019 (COVID-19) pandemic has infected >22.7 million and led to the deaths of 795,000 people worldwide. Patients with diabetes are highly susceptible to COVID-19–induced adverse outcomes and complications. The COVID-19 pandemic is superimposing on the preexisting diabetes pandemic to create large and significantly vulnerable populations of patients with COVID-19 and diabetes. This article provides an overview of the clinical evidence on the poorer clinical outcomes of COVID-19 infection in patients with diabetes versus patients without diabetes, including in specific patient populations, such as children, pregnant women, and racial and ethnic minorities. It also draws parallels between COVID-19 and diabetes pathology and suggests that preexisting complications or pathologies in patients with diabetes might aggravate infection course. Finally, this article outlines the prospects for long-term sequelae after COVID-19 for vulnerable populations of patients with diabetes.

Original languageEnglish (US)
Pages (from-to)2549-2565
Number of pages17
Issue number12
StatePublished - Dec 2020
Externally publishedYes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism


Dive into the research topics of 'Covid-19 and diabetes: A collision and collusion of two diseases'. Together they form a unique fingerprint.

Cite this